Literature DB >> 11115596

Evolving features of lung adenocarcinoma in Rio de Janeiro, Brazil.

M C Kaisermann1, A Trajman, K Madi.   

Abstract

Formerly considered rare, adenocarcinoma has become the commonest form of primary lung cancer in developed countries. Its clinical presentation has changed, with central tumors becoming more frequent. We reviewed all biopsies with a diagnosis of primary lung cancer obtained from October 1988 to April 1997 in a tertiary care hospital in Rio de Janeiro. Medical records from adenocarcinomas were analysed. Adenocarcinoma was the commonest form of lung cancer (168/409, 41%). Central tumors were observed in 43% according to radiological criteria and 47% according to bronchoscopic criteria. The frequency and clinical presentation of adenocarcinoma have evolved lately in Rio de Janeiro.

Entities:  

Mesh:

Year:  2001        PMID: 11115596     DOI: 10.3892/or.8.1.189

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.

Authors:  Yu Yao; Jing Luo; Qi Sun; Ting Xu; Siqing Sun; Meili Chen; Xin Lin; Qiuping Qian; Yu Zhang; Lin Cao; Po Zhang; Yong Lin
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

2.  Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer.

Authors:  Ning Li; Shaohui Liu; Mingjiao Sun; Wei Chen; Xiaogang Xu; Zhu Zeng; Yemin Tang; Yongquan Dong; Alex H Chang; Qiong Zhao
Journal:  Transl Oncol       Date:  2017-11-10       Impact factor: 4.243

3.  Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial.

Authors:  Yu-Tao Liu; Xue-Zhi Hao; De-Ruo Liu; Gang Cheng; Shu-Cai Zhang; Wen-Hua Xiao; Yi Hu; Jun-Feng Liu; Ming He; Cui-Min Ding; Li Zhang; Jun Wang; Hui Li; Gui-Lan Dong; Xiu-Yi Zhi; Jian Li; Yuan-Kai Shi
Journal:  Cancer Manag Res       Date:  2020-06-17       Impact factor: 3.989

4.  Analysis of the role of DAMTC in lung adenocarcinoma cells based on the DNA microarrays.

Authors:  Binliang Wang; Yuanyuan Cai; Yiming Kong; Xiaobo Li; Haiwei Fu; Song Zhang; Tianwei Zhang
Journal:  Oncol Lett       Date:  2019-03-15       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.